A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne
Conditions: Acne Vulgaris Interventions: Drug: Winlevi (clascoterone) 1%& Duac gel Sponsors: Sun Pharmaceutical Industries Limited Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Interest of High-dose Gentamicin Cement Associated With Clindamycin in Changes of Hip and Knee Prostheses
Conditions: Hip or Knee Replacement Sponsors: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
Conditions: Prosthetic-joint Infection; Infection Hip; Infection; Knee, Joint Interventions: Drug: Clindamycin; Drug: Rifampicin and levofloxacin Sponsors: Leiden University Medical Center; University Medical Center Groningen; Onze Lieve Vrouwe Gasthuis; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Medical Centre Leeuwarden; Isala; Martini Hospital Groningen; Radboud University Medical Center; Sint Maartenskliniek; Elisabeth-TweeSteden Ziekenhuis; Erasmus Medical Center; Alrijne Hospital; Spaarne Gasthuis; Reinier Haga Orthopedisch Centrum; Tergooi Hospital; Rijnstate Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections
Conditions: Streptococcal Sepsis; Invasive Group A Beta-Haemolytic Streptococcal Disease; Necrotizing Soft Tissue Infection; Infection, Bloodstream; Infection, Bacterial; Streptococcal Toxic Shock Syndrome Interventions: Drug: Linezolid; Drug: Clindamycin Sponsors: National Institutes of Health Clinical Center (CC); Emory University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Conditions: Carcinoma, Non-Small-Cell Lung Interventions: Drug: Amivantamab; Drug: Lazertinib; Drug: Doxycycline; Drug: Minocycline; Drug: Clindamycin; Drug: Chlorhexidine; Other: Noncomedogenic skin moisturizer Sponsors: Janssen Research& Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
The Potential Impact of Clindamycin on Neurosurgery Patients.
Conditions: Neurologic Complication; Neurosurgery Interventions: Drug: Clindamycin 600 mg; Drug: standard regimen Sponsors: Damanhour University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris
Condition: Acne Vulgaris Intervention: Drug: Clindamycin and Dapsone gel for 03 months Sponsor: Jinnah Postgraduate Medical Centre Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
